Trial intelligence / Profile preview

Moringa Leaf Capsules in Type 2 Diabetes

NCT06125873Phase 2Unknown

Sponsor
Islamabad Medical and Dental College
Start
Mar 2023
Primary completion
May 2024
Countries
1
01

Overview

Phase 2, randomised, open-label trial (2 arms), sponsored by Islamabad Medical and Dental College. Primary endpoints: Blood sugar level at 3 months and Glycated hemoglobin at 3 months. Status: unknown.

Beyond the preview

Go deeper on NCT06125873.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06125873.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call